137 related articles for article (PubMed ID: 38158963)
1. [Study of urinary markers of different podocytopathies by proteomic analysis].
Vinogradov AA; Chebotareva NV; Bugrova AE; Brzhozovskiy AG; Krasnova TN; Nasibullina KZ; Kononikhin AS; Moiseev SV
Ter Arkh; 2023 Aug; 95(6):457-461. PubMed ID: 38158963
[TBL] [Abstract][Full Text] [Related]
2. Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.
Chebotareva NV; Vinogradov A; Brzhozovskiy AG; Kashirina DN; Indeykina MI; Bugrova AE; Lebedeva M; Moiseev S; Nikolaev EN; Kononikhin AS
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293475
[TBL] [Abstract][Full Text] [Related]
3. Focal and Segmental Glomerulosclerosis and Membranous Nephropathy overlapping in a patient with Nephrotic Syndrome: a case report.
Silva CAD; Custódio FB; Monteiro MLGDR; Araújo SA; Araújo LS; Côrrea RRM; Reis MAD; Machado JR
J Bras Nefrol; 2020 Mar; 42(1):113-117. PubMed ID: 30806447
[TBL] [Abstract][Full Text] [Related]
4. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
Pérez V; López D; Boixadera E; Ibernón M; Espinal A; Bonet J; Romero R
BMC Nephrol; 2017 Feb; 18(1):49. PubMed ID: 28158993
[TBL] [Abstract][Full Text] [Related]
5. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis.
Zhang C; Zhang W; Chen HM; Liu C; Wu J; Shi S; Liu ZH
Am J Kidney Dis; 2015 Feb; 65(2):223-32. PubMed ID: 25218681
[TBL] [Abstract][Full Text] [Related]
7. Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome.
Suresh CP; Saha A; Kaur M; Kumar R; Dubey NK; Basak T; Tanwar VS; Bhardwaj G; Sengupta S; Batra VV; Upadhyay AD
Clin Exp Nephrol; 2016 Apr; 20(2):273-83. PubMed ID: 26351173
[TBL] [Abstract][Full Text] [Related]
8. Urinary podocytes in primary focal segmental glomerulosclerosis.
Hara M; Yanagihara T; Kihara I
Nephron; 2001 Nov; 89(3):342-7. PubMed ID: 11598401
[TBL] [Abstract][Full Text] [Related]
9. Urine biomarkers predict the cause of glomerular disease.
Varghese SA; Powell TB; Budisavljevic MN; Oates JC; Raymond JR; Almeida JS; Arthur JM
J Am Soc Nephrol; 2007 Mar; 18(3):913-22. PubMed ID: 17301191
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy.
Deegens JK; Wetzels JF
Minerva Urol Nefrol; 2005 Sep; 57(3):211-36. PubMed ID: 15986018
[TBL] [Abstract][Full Text] [Related]
11. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
[TBL] [Abstract][Full Text] [Related]
12. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
[TBL] [Abstract][Full Text] [Related]
13. Comparative proteomic analysis of children FSGS FFPE tissues.
Ni J; Tian S; Bai L; Lv Q; Liu J; Liu J; Fang Y; Zhai Y; Shen Q; Rao J; Ding C; Xu H
BMC Pediatr; 2022 Dec; 22(1):707. PubMed ID: 36503536
[TBL] [Abstract][Full Text] [Related]
14. Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis.
Kalantari S; Nafar M; Rutishauser D; Samavat S; Rezaei-Tavirani M; Yang H; Zubarev RA
BMC Nephrol; 2014 Sep; 15():141. PubMed ID: 25182141
[TBL] [Abstract][Full Text] [Related]
15. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.
He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM
BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological features of idiopathic membranous nephropathy with focal segmental sclerosis.
Li J; Chen B; Gao C; Huang J; Wang Y; Zhang S; Xu Y; Guo W; Wang R
BMC Nephrol; 2019 Dec; 20(1):467. PubMed ID: 31842785
[TBL] [Abstract][Full Text] [Related]
17. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
[TBL] [Abstract][Full Text] [Related]
18. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.
Park CW; Song HC; Shin YS; Ahn SJ; Kim YS; Kim SY; Choi EJ; Chang YS; Bang BK
Nephron; 1998; 79(1):44-9. PubMed ID: 9609461
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
Senthil Nayagam L; Ganguli A; Rathi M; Kohli HS; Gupta KL; Joshi K; Sakhuja V; Jha V
Nephrol Dial Transplant; 2008 Jun; 23(6):1926-30. PubMed ID: 17989103
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of anti-nephrin antibodies in podocytopaties among adults.
Chebotareva N; Vinogradov A; Birukova Y; Alentov I; Sergeeva N; Chemodanova D; Kononikhin AS; Moiseev SV
Nephrology (Carlton); 2024 Feb; 29(2):86-92. PubMed ID: 37864506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]